N@N

Eliana Merle Maintained (BNTX) at Hold with Increased Target to $300 on, Aug 27th, 2021

Eliana Merle of UBS, Maintained "BioNTech SE" (BNTX) at Hold with Increased Target from $111 to $300 on, Aug 27th, 2021.

Eliana has made no other calls on BNTX in the last 4 months.

There are 6 other peers that have a rating on BNTX. Out of the 6 peers that are also analyzing BNTX, 3 agree with Eliana's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Daina Graybosch of "SVB Leerink" Maintained at Hold with Increased Target to $293 on, Friday, August 13th, 2021
• Robert Burns of "HC Wainwright & Co." Maintained at Hold with Increased Target to $330 on, Wednesday, August 11th, 2021
• Chris Shibutani of "Goldman Sachs" Initiated at Hold and Held Target at $173 on, Tuesday, May 18th, 2021

These are the ratings of the 3 analyists that currently disagree with Eliana

---

• Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $450 on, Friday, August 20th, 2021
• Olga Smolentseva of "Bryan Garnier" Upgraded from Hold to Strong Buy and Held Target at $451 on, Wednesday, August 11th, 2021
• Simon Baker of "Redburn Partners" Downgraded from Hold to Strong Sell on, Wednesday, June 16th, 2021

Contributing Sources

---